Dong-A, Kwangdong Pharma to benefit from OTC sales at supermakets

Published: 2011-06-15 06:57:00

Updated: 2011-06-15 06:57:00

Shares of Dong-A Pharmaceutical and Kwangdong Pharmaceutical are expected to be boosted by expectations that their flagship products, Bacchus and Ssanwhatang drinks, may be reclassified into quasi-drugs, according to market watchers.

The Ministry of Health and Welfare said Thursday that it would allow some 20 over-the-counter (OTC) medicines to be sold at supermarkets and convenience stores....

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.